Guardant Health Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Guardant Health Inc 's ROA in the third quarter of 2026?
Guardant Health Inc recorded a cumulative net loss of $-485 million during 12 months ending in the third quarter of 2026, resulting in a negative return on assets (ROA) of -25.06%.

However, within the Healthcare sector 389 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 3592, from total ROA ranking in the second quarter of 2026 at 4268.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	48.71 %	43.7 %	42.48 %	-10.48 %	-8.5 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-485	-453	-433	-416	-399
Return On Assets (TTM)	-25.06 %	-25.47 %	-26.5 %	-27.91 %	-25.72 %
GH's Total Ranking	# 3592	# 4268	# 3777	# 3785	# 3833
Total Assets (TTM) in million	1,899	1,914	1,915	2,014	1,277
Seq. Total Assets Change	-0.81 %	-0.06 %	-4.89 %	57.71 %	-4.15 %
Seq. Net Income Change	-	-	-	-	-

GH's 5 Years Annual ROA >> Back to GH Management Effectiveness >> Compare GH ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 23
Sector	# 390
Overall	# 3539

Return On Assets Statistics
High	Average	Low
-5.33 %	-22.66 %	-39.83 %
(Jun 30 2019)		(Mar 31 2023)

Financial Statements
Guardant Health Inc 's Assets	$ 1,899 million	GH's Balance sheet
Guardant Health Inc 's Income	$ -124 million	Quarterly GH's Income Statement
GH's Income by Division		See GH's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	49.72 %	-17.51 %	13.42 %	-28.7 %	-9.84 %
Total Assets in million	2,014	1,345	1,630	1,438	2,016
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-416	-436	-479	-655	-385
Annual Return On Assets	-20.67 %	-32.44 %	-29.41 %	-45.54 %	-19.08 %

GH's 5 Years Annual ROA >> Back to GH Management Effectiveness >> Compare GH ROA to its Competitors

More Return On Assets Ratios
GH's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GH's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GH's Competitors
Subscribers only: Roa for Guardant Health Inc 's Suppliers
Subscribers only: Return On Assets for GH's Customers

You may also want to know
GH's Roi	GH's Inventory Turnover Ratio	GH's Growth Rates	GH's Dividend Comparisons
	GH's Profitability Ratios	GH's Asset Turnover Ratio	GH's Dividend Growth
GH's Roe	GH's Valuation Ratios	GH's Financial Strength Ratios	GH's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector

ROA

Date modified: 2026-11-06T13:00:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.